Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine
Cristina Eguizabal1, Nuria Montserrat, Anna Veiga
1Center for Regenerative Medicine in Barcelona.
Seminars in Reproductive Medicine
|January 19, 2013
Summary
Regenerative medicine aims to repair damaged tissues by understanding cell plasticity, including dedifferentiation, transdifferentiation, and reprogramming. Studying these processes in various models can advance human regenerative therapies.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Developmental Biology
Background:
- The primary objective of regenerative medicine is tissue repair and replacement.
- Understanding cellular plasticity is crucial for achieving this goal.
- Key processes include dedifferentiation, transdifferentiation, and reprogramming.
Purpose of the Study:
- To detail the fundamental regeneration processes.
- To explore cellular mechanisms underlying tissue repair.
- To inform the development of future human regenerative strategies.
Main Methods:
- Comparative analysis of regenerative processes in nonmammal and mammal models.
- Investigation of natural regeneration phenomena.
- Study of artificially induced cellular transformations.
Main Results:
- Identified key cellular mechanisms in regeneration.
- Highlighted the importance of cell plasticity (dedifferentiation, transdifferentiation, reprogramming).
- Demonstrated the utility of diverse model systems.
Conclusions:
- A comprehensive understanding of regeneration is essential for advancing medicine.
- Studying both natural and artificial processes provides critical insights.
- This knowledge is foundational for developing novel human regenerative therapies.
Related Concept Videos
Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...
Introduction to Nuclear Reprogramming
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

